MENU
BIVI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioVie (BIVI) Ownership - Who owns BioVie?

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers... Show more

Profile

Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.93M
P/E Ratio
N/A
Total Cash
24.98M
Projected Growth
N/A
Total Debt
332.73K
Revenue
N/A
Risk (Beta)
-2.23
Dividend Yield
N/A
Total Cash/Share
3.31
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BIVI
Capitalization
10.9M
P/E Ratio
N/A
Risk (Beta)
-2.23
Dividend Yield
N/A
Total Cash
25M
Total Cash/Share
3.31
Total Debt
333K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
24.9M
P/B Ratio
0.44
Cash Flow
N/A
Earnings
-6.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
754
Current Ratio
15.83
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.17M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-77.26
Shares Held By Institutions
2.66M
Shares Outstanding - Current
7.54M
Total Liabilities
1.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-92.450
View a ticker or compare two or three
BIVI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
680 W Nye Lane
Phone
+1 775 888-3162
Employees
13
Web
https://www.bioviepharma.com